Health and Biomedical Sciences
22Health Ventures
22Health Ventures is an early-stage venture firm, embedded in Singapore and including a venture fund providing capital to innovative healthtech entrepreneurs, alongside a value-add services platform supporting Singapore’s healthtech innovation ecosystem to help startups become globally competitive.
Altara Ventures
Altara is a Series A stage venture capital firm headquartered in Singapore and focused on technology investments across Southeast Asia.
ClavystBio
ClavystBio’s mission is to accelerate the commercialization of life sciences breakthroughs into human health impact. They invest and partner with innovators, entrepreneurs and founders to launch and grow global companies in Singapore
Coronet Ventures
Coronet Ventures Singapore-based venture unit of Cedars-Sinai Medical Centre. Coronet Ventures is interested in early-stage healthcare and biomedical science startups.
Kurma Partners
Kurma Partners finances innovation to build the healthcare industry of tomorrow. Kurma invests from company inception to growth in biotechnology, digital health and diagnostics and others. Based in Paris and Munich with global reach, Kurma contributes to innovation ecosystems in Europe and beyond.
Lightstone Singapore
Lightstone invests in early-stage, therapeutic-oriented, life science companies. Their goal is to find breakthrough therapies that have the potential to change the practice of medicine and they are committed to seeking out novel, disruptive and defensible technologies to meet unmet clinical needs.
MassMutual Ventures
MassMutual Ventures is a multistage global venture capital firm with teams based in Singapore, London and Boston, managing over $1 billion in investment capital. The fund’s investment focus is on fintech, digital health, enterprise SaaS, climate SaaS, and web3 and crypto infrastructure.
NSG Ventures
NSG Ventures is a global biotech venture capital firm started and managed by scientific experts, seasoned operators, investors, and drug development professionals of successful biotech companies. Their investment focus is to back and build early-stage transformative drug discovery companies globally.
Trinity Innovation Bioventure Singapore
Trinity Innovation Bioventure Singapore (TIBS) is a Singapore-based VC specialising in early-stage biotech investment globally. As an investor, we support passionate scientists and entrepreneurs in transforming cutting-edge scientific research into successful ventures. We have invested over $300m in over 30 portfolio companies across Asia.
Verge HealthTech Fund
Verge HealthTech Fund invests globally and exclusively into impactful health technology startups at their earliest stages. Their team has invested in 46 healthtech startups across 20 countries, impacting over 40 million lives.